Orexin receptor blockers: A tool for lowering alcohol intake and alcohol addictive behavior in the light of preclinical studies
By:
Authors
Kamila Czora-Poczwardowska
Department of Pharmacology, Poznan University of Medical Sciences, Poznań, Poland
Radosław Kujawski
Department of Pharmacology, Poznan University of Medical Sciences, Poznań, Poland
Julia Słyńko-Krzyżostaniak
Department of Pharmacology, Poznan University of Medical Sciences, Poznań, Poland
Przemysław Ł. Mikołajczak
Department of Pharmacology, Poznan University of Medical Sciences, Poznań, Poland
Department of Pharmacology and Phytochemistry, Institute of Natural Fibers and Medicinal Plants, Plewiska, Poland
Michał Szulc
Department of Pharmacology, Poznan University of Medical Sciences, Poznań, Poland
DOI: https://doi.org/10.2478/ahem-2021-0007 | Journal eISSN: 1732-2693
Language: English
Page range: 959 - 969
Submitted on: Aug 16, 2020
Accepted on: Apr 16, 2021
Published on: Dec 29, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2021 Kamila Czora-Poczwardowska, Radosław Kujawski, Julia Słyńko-Krzyżostaniak, Przemysław Ł. Mikołajczak, Michał Szulc, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.